Processing PDF: /home/ngobiro/projects/pngobiro.github.io/colleges/kmtc/diploma/Diploma in Kenya Registered Community Health Nursing/Year 1/Microbiology and Immunology/notes/IMMUNOLOGY lectures/pdfs/23B. Secondary Immune Deficiencies handout.pdf
Starting PDF processing...
PDF processing started. ID: 2025_06_15_8298b49773d06138fce6g
Polling PDF status (ID: 2025_06_15_8298b49773d06138fce6g)...
Attempt 1: Status = completed, Progress = 100.0%
PDF processing completed successfully.
Fetching MMD result (ID: 2025_06_15_8298b49773d06138fce6g)...

--- Converted MMD Start ---
Secondary Immune Deficiencies.
Learning Objectives:
-The causes of acquired immune deficiency.
-A relative immune compromise occurring with normal aging.
- Molecular Biology of HIV and AIDS
-Cellular immune dysfunction due to AIDS.
-Immune response to HIV infection.
-Therapeutic and vaccine targets in HIV infection, and the draw backs.

\section*{Introduction.}
- Acquired immune deficiencies may be caused by infection with a virus.
- Also, a relative immune compromise occurs with normal aging.
- Cancer, chronic disease, severe protein loss, liver disease- all cause a general diminution of the immune response.
- Some are due to decreases in systemic immune globulins (protein wasting diseases, malnutrition);
- Others are probably due to systemic effects of cytokines (some viral diseases, cancer);
- Still others are due to unknown cause (liver disease).
- Perhaps the most frequently overlooked is the role of the physician in producing immune compromise.
- Immunological suppressants such as corticosteroids, chemotherapy, some potent antimicrobials, and transplant medications can produce profound immune deficiencies that may lead to the death of the individual.
- The lecture will concentrate on a disease that produces profound immune deficiency through a relatively selective depletion of CD4+ lymphocytes.
- AIDS, first described in 1981 and, has been the subject of countless research publications and articles.

\section*{Human Immunodeficiency Virus.}
- The human immunodeficiency virus (HIV) is the causative agent in the acquired immune deficiency syndrome (AIDS).
- Need to be conversant with molecular biology of HIV as a virus.
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-2.jpg?height=587&width=782&top_left_y=319&top_left_x=224)

\author{
1981: A new disease \\ - Demographic groups-- homosexuals, IV drug abusers, hemophiliacs \\ - Infections with opportunistic organisms \\ - Unusual cancers-- CNS lymphoma, Kaposi's sarcoma \\ - Decreased CD4+ T cells
}
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-2.jpg?height=587&width=779&top_left_y=1078&top_left_x=223)
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-2.jpg?height=587&width=773&top_left_y=1078&top_left_x=1126)

\section*{HIV: Acute and Chronic Disease}

\section*{Opportunistic Infections}
- Acute infection-- flu-like illness with fever, weakness, lymphadenopathy
- Pneuomocystis carinii pneumonia (PCP)
- HIV-associated wasting syndrome
- TB (tuberculosis)
- Latency- period of years during which
- MAI (an atypical mycobacterium) infection is active but symptoms are few
- HSV
- Chronic disease-- diminished CD4 T cell
- Bacterial pneumonias count contributes to immunodeficiency and
- Toxoplasmosis secondary infection with opportunistic
- CMV organisms
- Other things-- dementia, Kaposi sarcoma

\section*{Diagnosis}
- ELISA for anti-HIV antibodies
- Western blot using patient serum against viral proteins
- PCR for viral RNA in serum

\section*{Modes of Transmission}
- Blood and body fluids
- Sexual transmission: male:male >> male:female
- IVDA
- During birth or nursing
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-3.jpg?height=591&width=785&top_left_y=1076&top_left_x=220)
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-3.jpg?height=589&width=781&top_left_y=1077&top_left_x=1122)
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-3.jpg?height=598&width=787&top_left_y=1834&top_left_x=222)
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-3.jpg?height=594&width=781&top_left_y=1839&top_left_x=1122)
\begin{tabular}{|l|l|l|}
\hline \multicolumn{3}{|c|}{HIV Functional gene products.} \\
\hline \multicolumn{3}{|c|}{\multirow[t]{7}{*}{\begin{tabular}{l}
narm \\
Probater anoday \\
Namesion elemoodentinotement \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=18\&width=141\&top_left_y=427\&top_left_x=611) \\
Norwomperate intervity \\
Forminger consposter loper \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=24\&width=197\&top_left_y=477\&top_left_x=612) \\
frwellipershpooretellee \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=16\&width=314\&top_left_y=527\&top_left_x=611) \\
and mosuretifut spoes \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=17\&width=259\&top_left_y=549\&top_left_x=611) \\
Bropen \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=18\&width=282\&top_left_y=592\&top_left_x=611) \\
Hestremse toonsorestanc-dowive \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=17\&width=241\&top_left_y=617\&top_left_x=612) \\
(n) itrogries) \\
Avg bersperawits \\
pute \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=20\&width=304\&top_left_y=667\&top_left_x=612) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=19\&width=339\&top_left_y=689\&top_left_x=611) Soullymeried \\
pay \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=23\&width=299\&top_left_y=741\&top_left_x=609) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=19\&width=330\&top_left_y=765\&top_left_x=610) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=16\&width=303\&top_left_y=778\&top_left_x=609) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=17\&width=132\&top_left_y=790\&top_left_x=609) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=21\&width=333\&top_left_y=807\&top_left_x=609) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=21\&width=307\&top_left_y=831\&top_left_x=609) \\
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=19\&width=192\&top_left_y=843\&top_left_x=609)
\end{tabular}}} \\
\hline & & \\
\hline & & \\
\hline & & \\
\hline & & \\
\hline & & \\
\hline & & \\
\hline
\end{tabular}
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-4.jpg?height=2107&width=1680&top_left_y=318&top_left_x=223)

\section*{The immune response to HIV}
- Antibodies (some neutralize)
- Cytotoxic T Cells
- Complement
- NK Cells

The antibody response to HIV

In HIV infection, antibodies to all major structural proteins of virion (gag, pol, env) are made, but only antibodies to env protein have the potential to be neutralizing. In fact, only a subset of anti-env antibodies are neutralizing.
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-5.jpg?height=440&width=356&top_left_y=398&top_left_x=1516)
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-5.jpg?height=591&width=785&top_left_y=1076&top_left_x=220)

\section*{CD4+ T cell loss}
- Destruction by HIV cytopathic effect
- Destruction by CD8+ cytotoxic T cells
- Dendritic cells carry HIV to lymph nodes
- Bystander effects
- Diminished production
\begin{tabular}{|l|}
\hline \multicolumn{1}{|c|}{ Immune Evasion by HIV } \\
- Rapid mutation rate \\
- Nef protein suppresses class I MHC \\
- Switch from R5 to X4 strain co-receptor \\
- Depletion of $\mathrm{T}_{\mathrm{H}}$ cells; ? Inhibition of $\mathrm{T}_{\mathrm{c}}$ \\
cells \\
- Latency \\
\hline
\end{tabular}
![](https://cdn.mathpix.com/cropped/2025_06_15_8298b49773d06138fce6g-6.jpg?height=2113&width=1681&top_left_y=319&top_left_x=222)

\section*{Vaccine Strategies}
- Subunit vaccine-- recombinant protein plus adjuvant
- Attenuated virus vaccine-- like vaccinia for small pox
- Recombinant Virus vaccine
- DNA vaccine

\section*{Problems}
- No ideal animal model
- No correlates of immune state
- Diversity of strains; mutation
- Ethics of live virus vaccine trials
--- Converted MMD End ---
